$25.87
-0.55-2.08%
Últ. Act.: Oct 16, 5:36 PM
$25.80
-0.62-2.35%
Amphastar Pharma (AMPH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.62 | $0.69 | $0.91 | $0.79 |
| Actual | $0.91 | $0.42 | $0.73 | $0.93 |
| Surprise | +46.8% | -39.1% | -19.8% | +17.7% |
| Revenue | ||||
| Estimate | $180.4M | $172.9M | $191.7M | $184.9M |
| Actual | $183.9M | $171.2M | $183.1M | $191.8M |
| Surprise | +1.97% | -0.97% | -4.48% | +3.78% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.86 | $0.69 |
| Revenue | ||
| Consensus | $197.4M | $193.3M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0.91 | $0.62 | 46.8 % |
| Q1 | May 7, 2026 | $0.42 | $0.69 | -39.1 % |
| Q4 | Feb 26, 2026 | $0.73 | $0.91 | -19.8 % |
| Q3 | Nov 6, 2025 | $0.93 | $0.79 | 17.7 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $183.90M | $180.36M | 1.97 % |
| Q1 | May 7, 2026 | $171.17M | $172.85M | -0.97 % |
| Q4 | Feb 26, 2026 | $183.11M | $191.70M | -4.48 % |
| Q3 | Nov 6, 2025 | $191.84M | $184.86M | 3.78 % |